What Users Report During Week 1 on GLP-1s
A synthesis of the patterns that keep showing up in patient stories about their first week on semaglutide, tirzepatide, and other GLP-1 medications.
The starter doses of GLP-1 medications — 0.25mg for semaglutide, 2.5mg for tirzepatide — are intentionally low. They are not designed to drive weight loss on their own; they exist so the body can meet the medication gently. That gentle introduction is reflected in what people tend to report during week one: shifts are usually subtle, sometimes barely noticeable, and occasionally a little uncomfortable.
What follows is a synthesis of the patterns that come up again and again in public conversations among GLP-1 users — not quotes from any individual, but the broad themes that recur. None of these are universal, and your week one may not look like any of them. The point is to give you a sense of the range so you have context if something surprising shows up.
We have anchored these patterns to what the clinical literature describes where possible. Nausea, fatigue, and reduced appetite are documented as the most common adverse effects of both semaglutide and tirzepatide. The other patterns below — feeling cold, vivid dreams, an oddly "quiet" relationship with food — are reported widely enough in patient communities to be worth naming, even where formal data is thin.
The patterns
A quieter appetite, but rarely a dramatic one
The single most common pattern is a subtle reduction in hunger rather than a sudden disappearance of it. People often describe noticing they did not finish their plate, forgot to snack, or felt full earlier than expected. At starter doses, the change is usually mild enough that you have to look for it. Dramatic appetite drops are more common later, once the dose has stepped up.
Mild nausea, often after meals
Nausea is the most commonly reported side effect across GLP-1s, and it tends to show up most after richer or larger meals. Patient communities consistently describe a low-grade queasiness that comes and goes, often peaking in the first 24-72 hours after the injection. The official prescribing information for semaglutide echoes this: nausea is generally transient and resolves for most people as the body adapts.
Fatigue that creeps up mid-week
A lot of people describe a sleepy or low-energy stretch in the first three or four days. This often coincides with eating less than usual, which means lower calorie intake on top of a body that is busy adjusting. The fatigue is usually mild and lifts on its own; staying hydrated and getting adequate protein early tends to help.
Feeling cold more easily
A recurring report — especially from people who are eating noticeably less — is a sense of being chillier than usual. Lower food intake can mean a lower thermic effect of digestion, which some people notice as cold hands, cold feet, or just wanting another layer. This pattern is anecdotal rather than formally documented, but it shows up often enough in the community that it is worth naming.
Vivid dreams for some
A subset of people report unusually vivid or memorable dreams in the first week or two. The reason is unclear and the pattern is not universal, but it is reported widely enough that newcomers often ask about it. For most people who notice it, the dreams normalize within a few weeks.
"Food noise" starting to quiet
Perhaps the most distinctive pattern, even in week one for some people, is a noticeable drop in intrusive food thoughts — what users call "food noise." The constant background hum of "when do I get to eat next" tends to soften. At starter doses this is often partial and inconsistent, but many people describe it as the first sign the medication is doing something real.
Almost nothing happening at all
A surprisingly large share of people describe their first week as uneventful. No appetite change, no side effects, no scale movement. This is normal too. The starter dose is meant to be a gentle introduction, and many people only feel something meaningful after the first dose increase several weeks in.
What this means for you
If your week one is uneventful, that does not mean the medication is not working. The starter dose is sub-therapeutic by design, and the effects tend to build with later titrations. If you feel mild side effects, treat them as expected unless they become severe; eating smaller, lighter meals and prioritizing hydration helps most people through the first week comfortably.
What matters most this week is putting the boring infrastructure in place. Pick a consistent injection day. Set a recurring reminder. Start tracking protein loosely. Pay attention to your hunger and fullness signals, because they are going to start sending different messages over the next few weeks, and the more familiar you are with your baseline, the easier the changes will be to interpret.
If anything feels seriously wrong — persistent vomiting, severe abdominal pain, signs of dehydration — that is not a "first week pattern." That is a call-your-provider situation. The patterns above are the normal range; the outliers deserve medical attention.
Common questions
Common Concerns
Is it normal to feel nothing in week one?expand_more
Why am I so tired this week?expand_more
Is feeling cold a real side effect?expand_more
How much weight will I lose in week one?expand_more
When should I call my doctor?expand_more
Keep exploring
Browse all GLP-1 guides.